The USC Michelson Center for Convergent Bioscience is celebrating the fifth anniversary of its opening in 2017. Dr. Gary K. Michelson recently visited the center to learn about the latest research being conducted with state-of-the-art equipment.
The USC Michelson Center for Convergent Bioscience brings together a diverse network of scientists and engineers from the USC Dornsife College of Letters, Arts and Sciences, USC Viterbi School of Engineering and Keck School of Medicine of USC to solve some of the greatest intractable problems of the 21st century – from cancer, to neurological disease, to cardiovascular disease.
The team of world-class scientists representing several disciplines – biological sciences, chemistry, computer science, engineering, medicine, nanomedicine, neuroscience, and physics – will be the catalyst that precipitates a sea change in research and development at USC and the world, establishing a model for innovation in precision medicine that quickly translates from the bench to the bedside in the form of new drug therapies, cures, high-tech diagnostics and biomedical devices.
With a generous founding gift of $50 million from Alya and Dr. Michelson, a retired orthopedic spinal surgeon, the USC Michelson Center for Convergent Bioscience is an opportunity for USC to transform and influence the course of scientific discovery and biomedicine for generations to come.
Read more about the innovative research being conducted at the USC Michelson Center for Convergent Bioscience: